You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
The supplement adds a collection vial to the BD Onclarity test and includes performance data for the BD Viper LT and the BD COR Systems.
The researchers found that changes in histone modification at HPV integration events were correlated with upregulation of nearby genes and endogenous retroviruses.
The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.
The test, which is used to screen for cervical cancer, was previously approved by the agency for use with the Cobas 4800 system.
Profiling microbial communities in cervicovaginal samples from women carrying high-risk HPV strains, researchers found possible markers of pre-cancer progression.
In PLOS this week: signs of selection on microRNA targets, HPV sequences as markers of cervical cancer, and more.
The system showed good performance for cervical samples as well as orophyrengeal samples, and required no extraction step.
The flow cytometry-based assays were developed by Menlo Park, California-based IncellDx to run on Beckman Coulter instrumentation.
Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.
Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.
A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.
In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.